Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Bil

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Biomedicines|November 27, 2025
Dedicated Bifurcation Stents vs. Regular Drug-Eluting Stents in Coronary Bifurcation Treatment: A Systematic Review and Meta-Analysis of 1-Year and 4-Year Outcomes, Including Left Main and Non-Left Main Subgroup ComparisonsJacek Bil, Adam Kern, Aneta I Gziut-Rudkowska, et al.
Journal of Personalized Medicine|May 27, 2023
The Comparison of Predicting Factors and Outcomes of MINOCA and STEMI Patients in the 5-Year Follow-UpPatryk Buller, Adam Kern, Maciej Tyczyński, et al.
Kardiologia Polska|September 15, 2022
When an interventional cardiologist needs to be a vascular surgeon: Successful management of coronary stent loss in a nonagenarianAdam Kern, Tomasz Godlewski, Robert Gil, et al.
European Journal of Clinical Investigation|May 31, 2017
Platelet distribution width as the prognostic marker in coronary bifurcation treatmentAdam Kern, Robert J Gil, Krystian Bojko, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|May 3, 2019
Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcationsRobert J Gil, Jacek Bil, Adam K Kern, et al.
The International Journal of Cardiovascular Imaging|October 2, 2017
Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-upRobert J Gil, Jacek Bil, Jacek Legutko, et al.
Journal of Personalized Medicine|December 23, 2023
Significance of S100B Protein as a Rapid Diagnostic Tool in Emergency Departments for Traumatic Brain Injury PatientsRakesh Jalali, Izabela Godlewska, Magdalena Fadrowska-Szleper, et al.
Medicine|April 5, 2019
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stentRobert J Gil, Tomasz Pawłowski, Jacek Legutko, et al.
European Journal of Clinical Investigation|March 30, 2021
6-year results of BiOSS stents in coronary bifurcation treatmentRobert J Gil, Adam Kern, Radoslaw Formuszewicz, et al.
Kardiologia Polska|January 19, 2016
The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatmentRobert J Gil, Jacek Bil, Tomasz Pawłowski, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Biomedicines|November 27, 2025
Dedicated Bifurcation Stents vs. Regular Drug-Eluting Stents in Coronary Bifurcation Treatment: A Systematic Review and Meta-Analysis of 1-Year and 4-Year Outcomes, Including Left Main and Non-Left Main Subgroup ComparisonsJacek Bil, Adam Kern, Aneta I Gziut-Rudkowska, et al.
Journal of Personalized Medicine|May 27, 2023
The Comparison of Predicting Factors and Outcomes of MINOCA and STEMI Patients in the 5-Year Follow-UpPatryk Buller, Adam Kern, Maciej Tyczyński, et al.
Kardiologia Polska|September 15, 2022
When an interventional cardiologist needs to be a vascular surgeon: Successful management of coronary stent loss in a nonagenarianAdam Kern, Tomasz Godlewski, Robert Gil, et al.
European Journal of Clinical Investigation|May 31, 2017
Platelet distribution width as the prognostic marker in coronary bifurcation treatmentAdam Kern, Robert J Gil, Krystian Bojko, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|May 3, 2019
Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcationsRobert J Gil, Jacek Bil, Adam K Kern, et al.
The International Journal of Cardiovascular Imaging|October 2, 2017
Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-upRobert J Gil, Jacek Bil, Jacek Legutko, et al.
Journal of Personalized Medicine|December 23, 2023
Significance of S100B Protein as a Rapid Diagnostic Tool in Emergency Departments for Traumatic Brain Injury PatientsRakesh Jalali, Izabela Godlewska, Magdalena Fadrowska-Szleper, et al.
Medicine|April 5, 2019
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stentRobert J Gil, Tomasz Pawłowski, Jacek Legutko, et al.
European Journal of Clinical Investigation|March 30, 2021
6-year results of BiOSS stents in coronary bifurcation treatmentRobert J Gil, Adam Kern, Radoslaw Formuszewicz, et al.
Kardiologia Polska|January 19, 2016
The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatmentRobert J Gil, Jacek Bil, Tomasz Pawłowski, et al.
Pageof 13